-
Brazil Oligo PDP Project Launched
Great news for 5q Spinal Muscular Atrophy (SMA) patients in Brazil!
-
Joint Agreement Signed
Joint Agreement Signed Between Shanghai Institute of Biomedical Technologies and Aurisco Pharmaceutical Co., Ltd.
-
Successful FDA inspection at Aurisco
Aurisco Pharmaceutical today announced that its manufacturing site in Badu, Tiantai has successfully passed a USFDA cGMP inspection, which lasted for 5 days , from March 17 to March 21,2025. The inspection conclusion is NAI (No Action Indicated).
-
Brazil President Met Aurisco Chairman
On May 12, 2025, Luiz Inácio Lula da Silva, President of the Federative Republic of Brazil, met with Peng Zhien, Chairman of Aurisco in Beijing.
-
Joint AI Oligonucleotide Drugs Lab Established
East China Normal University and Aurisco Pharmaceutical Co., Ltd. jointly inaugurated AI-Driven Oligonucleotide Drugs Discovery Laboratory. The signing and inauguration ceremony of the AI-Driven Oligonucleotide Drugs Discovery Joint Laboratory was held at East China Normal University's Putuo Campus.
Follow Aoruite WeChat official account